Brief: BrainsWay Announces Publication of Deep TMS™ Trial Results for Reduction of Heavy Drinking in Alcohol-Dependent Subjects
09/12/2021 14:10
Dec 9 (Reuters) - Brainsway Ltd BWAY.TA :
* BRAINSWAY ANNOUNCES PUBLICATION OF DEEP TMS™ TRIAL RESULTS
FOR
REDUCTION OF HEAVY DRINKING IN ALCOHOL-DEPENDENT SUBJECTS
* BRAINSWAY LTD - STUDY FINDINGS TO BE FEATURED TODAY AT
BRAIN
STIMULATION CONFERENCE SYMPOSIUM
* BRAINSWAY LTD - NO SERIOUS ADVERSE EVENTS OR SIDE EFFECTS
WERE
REPORTED IN STUDY.
Source text for Eikon: ID:nGNX2m10zK
Further company coverage: BWAY.TA
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)